LEO Sarath takes your privacy seriously. Please read the following to learn more about our privacy policy.
This policy covers how www.leo-sarath.com treats personal information that www.leo-sarath.com collects and receives, including information related to your past use of www.leo-sarath.com services. Personal information; is information about you that is personally identifiable like your name, address, email address, or phone number, and that is not otherwise publicly available.
Information Sharing and Disclosure
www.leo-sarath.com does not rent, sell, or share personal information about you with other people or nonaffiliated companies except to provide services you've requested, when we have your permission, or under the following circumstances:
We provide the information to trusted partners who work on behalf of or with LEO Sarath under confidentiality agreements. These companies may use your personal information to help LEO Sarath communicate with you about services from www.leo-sarath.com. However, these companies do not have any independent right to share this information.
We request a parent's permission to share the information if the user is a child under age 13. Parents have the option of allowing LEO Sarath to collect and use their child's information without consenting to LEO Sarath sharing of this information with people and companies who may use this information for their own purposes;
We respond to subpoenas, court orders, or legal process, or to establish or exercise our legal rights or defend against legal claims;
We believe it is necessary to share information in order to investigate, prevent, or take action regarding illegal activities, suspected fraud, situations involving potential threats to the physical safety of any person, violations of www.leo-sarath.com's terms of use, or as otherwise required by law.
FDA Approves Taclonex Scalp® - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis. Warner Chilcott and LEO Pharma announced 12 May that the FDA has approved...
Read more
1-10-2009 - LEO Pharma acquires own portfolio in the US LEO Pharma A/S, a world leader in treatment of dermatological diseases, has re-acquired the US-rights to the company’s psoriasis portfolio and dermatology pipeline from the previous partner in the US, Warner Chilcott. The transaction sum is set at...Read More